Investigation of a Therapeutic Vaccine (ACIT-1) in Cancer
Clinical trial NCT03096093 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03096093
- Sponsor
- Cancer Vaccines Limited
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-25
- Primary completion
- 2026-12-01
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.